Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathway

Yuanyuan Tu,E Song,Zhenzhen Wang,Na Ji,Linling Zhu,Kun Wang,Haotian Sun,Yuting Zhang,Qiujian Zhu,Xiaojuan Liu,Manhui Zhu

DOI: https://doi.org/10.1016/j.biopha.2021.111274

2021-05-01

Abstract:<p>Oxidative stress and inflammation are important pathogenic factors of diabetic retinopathy (DR). DR remains the most common ocular complication caused by diabetes mellitus (DM) and is the leading cause of visual impairment in working-aged people worldwide. Melatonin has attracted extensive attention due to its potent antioxidant and anti-inflammatory effects. In the present study, melatonin inhibited oxidative stress and inflammation by enhancing the expression and activity of silent information regulator factor 2-related enzyme 1 (Sirt1) both in in vitro and in vivo models of DR, and the Sirt1 inhibitor EX-527 counteracted melatonin-mediated antioxidant and anti-inflammatory effects on Müller cells. Moreover, melatonin enhanced Sirt1 activity through the maternally expressed gene 3 (MEG3)/miR-204 axis, leading to the deacetylation of the Sirt1 target genes forkhead box o1 (Foxo1) and nuclear factor kappa B (NF-κB) subunit p65, eventually contribute to the alleviation of oxidative stress and inflammation. The study revealed that melatonin promotes the Sirt1 pathway, thereby protecting the retina from DM-induced damage.</p>

pharmacology & pharmacy,medicine, research & experimental

What problem does this paper attempt to address?

This paper aims to investigate the inhibitory effects of melatonin on oxidative stress and inflammation in Müller cells in diabetic retinopathy (DR) through the activation of the Sirt1 pathway and its specific mechanisms.

### Main Research Questions:
1. **Can melatonin inhibit oxidative stress and inflammation in diabetic retinopathy by activating the Sirt1 pathway?**
2. **Through what mechanisms does melatonin promote the expression and activity of Sirt1?**
3. **What is the specific role of Sirt1 in Müller cells?**

### Research Background and Objectives:
- **Diabetic Retinopathy (DR)**: One of the most common complications of diabetes, severely affecting the vision of the working-age population.
- **Oxidative Stress and Inflammation**: Considered important pathogenic factors in DR.
- **Müller Cells**: As the main glial cells of the retina, they play a key role in the development and progression of DR.

### Research Methods:
- **Cell Experiments**: Culturing primary Müller cells from mice, using high glucose (HG) treatment to simulate a diabetic environment, and adding melatonin or the Sirt1 inhibitor EX-527.
- **Animal Experiments**: Inducing a diabetic model in mice and treating them with melatonin or EX-527.
- **Molecular Detection**: Including techniques such as Western blot, immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and quantitative real-time PCR.

### Research Results:
- **Melatonin Enhances Sirt1 Expression and Activity**: Melatonin significantly increased the expression and activity of Sirt1, and this effect was reversed by the Sirt1 inhibitor EX-527.
- **Melatonin Inhibits Oxidative Stress and Inflammation**: Melatonin increased the activity of antioxidant enzymes (such as SOD and CAT), reduced the content of lipid peroxidation product MDA, lowered the levels of reactive oxygen species (ROS), and inhibited the secretion of inflammatory cytokines (such as VEGF, TNF-α, IL-1β, and IL-6).
- **Melatonin Promotes Deacetylation of Foxo1 and NF-κB p65 through Sirt1**: Melatonin promoted the deacetylation of Foxo1 and NF-κB p65 by activating the Sirt1 pathway, thereby further inhibiting oxidative stress and inflammatory responses.
- **MEG3/miR-204 Axis Involved in Melatonin's Mechanism**: Melatonin influenced the expression and activity of Sirt1 by regulating the MEG3/miR-204 axis.

### Conclusion:
Melatonin alleviates oxidative stress and inflammation in diabetic retinopathy by activating the Sirt1 pathway, thereby protecting the retina from diabetic damage. This finding provides a new potential target for the treatment of DR.